Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2007
06/21/2007US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
06/21/2007US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases
06/21/2007US20070142409 3-Substituted-4-pyrimidone derivatives
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142391 Piperazine-2-carboxamide derivatives
06/21/2007US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
06/21/2007US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142373 Quinoline derivatives as phosphodiesterase inhibitors
06/21/2007US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide
06/21/2007US20070140960 Methods for imaging soluble a-beta
06/21/2007DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug
06/21/2007DE102005060468A1 Thienylpyridylcarboxamide Thienylpyridylcarboxamide
06/21/2007CA2637740A1 Fused pyrrole derivatives
06/21/2007CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
06/21/2007CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds
06/21/2007CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
06/21/2007CA2633023A1 Polycyclic indazole derivatives that are erk inhibitors
06/21/2007CA2632030A1 Compounds which modulate the cb2 receptor
06/21/2007CA2628952A1 Aspartic protease inhibitors
06/20/2007EP1798230A1 Substituted alkylamine derivatives and methods of use
06/20/2007EP1798229A1 Substituted biphenyl derivative
06/20/2007EP1797100A1 Nitrate esters and their use for mitigating cellular damage
06/20/2007EP1797080A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments
06/20/2007EP1797069A2 Hiv inhibiting 5-heterocyclyl pyrimidines
06/20/2007EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
06/20/2007EP1797040A1 Muscarinic receptor antagonists
06/20/2007EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1366043B1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
06/20/2007CN1984922A Substituted prolines as inhibitors of hepatitis c virus NS3 serine protease
06/20/2007CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders
06/20/2007CN1984901A Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors.
06/20/2007CN1984899A CXCR1 and CXCR2 chemokine antagonists
06/20/2007CN1984897A Light-emitting device material and light-emitting device
06/20/2007CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/20/2007CN1984888A Substituted azetidine compounds, their preparation and use as medicaments
06/20/2007CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/20/2007CN1984564A Aminocarbonyl-substituted thiensulphonylamino (thio) carbonyltriazolin (thi) ones, methods for production and use thereof
06/20/2007CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/19/2007US7232909 Pyridine derivatives
06/19/2007US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents
06/19/2007US7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
06/19/2007US7232834 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
06/19/2007US7232833 For therapy and prophylaxis of bacterial infections
06/19/2007US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
06/14/2007WO2007066678A1 Therapeutic agent for corneal/conjuctival disease
06/14/2007WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof
06/14/2007WO2007065948A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
06/14/2007WO2007065669A1 Biaryl compounds useful as agonists of the gpr38 receptor
06/14/2007WO2007065518A1 Pyridiazinone derivatives for tumour treatment
06/14/2007WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007WO2007050721A3 Heterocyclic aspartyl protease inhibitors
06/14/2007WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
06/14/2007WO2006051397A8 Oligonucleotide probes
06/14/2007WO2004043335A3 Methods of treating infection by drug resistant bacteria
06/14/2007US20070135654 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
06/14/2007US20070135642 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast
06/14/2007US20070135494 Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides
06/14/2007US20070135492 Cannabinoid receptor 1 antagonists (CB1); use of 1,2,4-tri-substituted imidazoline derivatives in the treatment of obesity; use in combination with lipase inhibitor orlistat or lipstatin
06/14/2007US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors
06/14/2007US20070135468 Pyridyloxyalkanoic acid amide derivatives useful as fungicides
06/14/2007US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors
06/14/2007US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors
06/14/2007US20070135402 Azetidine ring compounds and drugs comprising the same
06/14/2007US20070135357 Anti-hypercholesterolemic compounds
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/14/2007CA2632719A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
06/14/2007CA2632217A1 Pyridiazinone derivatives for the treatment of tumours
06/14/2007CA2632212A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007CA2631231A1 Therapeutic agent for corneal/conjuctival disease
06/13/2007EP1795526A1 N-substituted n-(4-piperidinyl)amide derivative
06/13/2007EP1794152A1 Method for manufacturing enantiomeric imidazole compounds
06/13/2007EP1794151A1 Dna-pk inhibitors
06/13/2007EP1794135A1 Substituted heterocyclic compounds and methods of use
06/13/2007EP1794130A1 Pyrazole compounds useful in the treatment of inflammation
06/13/2007EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i
06/13/2007EP1794117A2 Mercaptoamides as histone deacetylase inhibitors
06/13/2007EP1793826A2 Chemical compounds
06/13/2007EP1636213B1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
06/13/2007EP1611122B1 Substituted pyrazole compounds
06/13/2007EP1437353B1 Alkyl ether derivatives or salts thereof
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007CN1980934A Novel indole derivatives as selective androgen receptor modulators (sarms)
06/13/2007CN1980923A Polycyclic pyridines as potassium ion channel modulators
06/13/2007CN1980920A Thiophene derivatives, their manufacture and use as pharmaceutical agents
06/13/2007CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof
06/13/2007CN1980917A Novel indole derivatives as selective androgen receptor modulators (SARMS)
06/13/2007CN1980916A Chemokine receptor binding heterocyclic compounds
06/13/2007CN1978444A Photochromic thiophene pyrrole mixed linkage type dithienylethene compounds, and their synthesizing and use
06/13/2007CN1978443A Photochromic thiophene pyrazole heterocyclic mixed linkage type asymmetrical dithienylethene compounds, and their preparing method and use
06/13/2007CN1321101C New retinoids for the treatment of emphysema
06/12/2007US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor
06/12/2007US7230104 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
06/12/2007US7230100 Having a predominantly cis configuration by coupling an S-oxide of a 2-oxymethyl- thiolane, dithiolane or oxathiolane with a nucleoside base in the presence of a tertiary amine, a Lewis acid of a Group 1B or 2B metal catalyst and deprotecting the intermediate formed
06/12/2007US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer